Publications

Filter By:

Clear Filters

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

PCS6422

November 1, 2000

Grem JL.

View Publication

A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer

PCS6422

April 1, 2000

Schilsky RL, Bukowski R, Burris H 3rd, Hochster H, O'Rourke M, Wall JG, Mani S, Bonny T, Levin J, Hohneker J.

View Publication

Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil

PCS6422

February 1, 2000

Baker SD, Diasio RB, O'Reilly S, Lucas VS, Khor SP, Sartorius SE, Donehower RC, Grochow LB, Spector T, Hohneker JA, Rowinsky EK.

View Publication

Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol

Necrobiosis Lipoidica (NL)

November 1, 1996

Lillibridge JA, Kalhorn TF, Slattery JT.

View Publication

Individualizing therapy with 5-fluorouracil related to dihydropyrimidine dehydrogenase: theory and limits

PCS6422

August 1, 1996

Milano G, Etienne MC.

View Publication

Hemorrheologic effects of metabolites of pentoxifylline (Trental)

Necrobiosis Lipoidica (NL)

1995

Ambrus JL, Stadler S, Kulaylat M.

View Publication

Relationship between fluorouracil systemic exposure and tumor response and patient survival.

PCS6422

June 1, 1994

Milano G, Etienne MC, Renée N, Thyss A, Schneider M, Ramaioli A, Demard F.

View Publication

5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil

PCS6422

December 1, 1993

Baccanari DP, Davis ST, Knick VC, Spector T.

View Publication

Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy

PCS6422

November 15, 1993

Lu Z, Zhang R, Diasio RB.

View Publication

Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity

Necrobiosis Lipoidica (NL)

April 1, 1993

Semmler J, Gebert U, Eisenhut T, Moeller J, Schönharting MM, Alléra A, Endres S.

View Publication